
Kronox Lab Sciences: 64.26% Stake Transferred, New MD & Directors Appointed
Kronox Lab Sciences Limited announced the completion of a share purchase agreement where sellers Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani, and Mr. Jogindersingh Gianchand Jaswal transferred 2,38,44,000 equity shares (64.26% of total paid-up capital) to Indo Borax & Chemicals Limited on September 29, 2026. Consequently, the sellers ceased to be part of the promoter group, now holding 9.95% of the company's voting share capital. The Board of Directors approved this transfer and a significant change in management. Mr. Suresh Kalra was appointed as Managing Director and CEO, and Mr. Sunil Malhotra and Mr. Harsh Malhotra were appointed as Executive Directors, each for a five-year term. Additionally, Mr. Amit Kumar Sharma, Ms. Anuradha Suneet Maheshwari, and Mr. Dhananjay Tapasvi were appointed as independent directors for five years, subject to shareholder approval.
Key Highlights
- 64.26% stake (2.38 Cr shares) transferred to Indo Borax & Chemicals Limited.
- Original sellers ceased to be promoters, now hold 9.95% equity.
- Board approved Mr. Suresh Kalra as new MD & CEO for 5 years.
- Mr. Sunil Malhotra and Mr. Harsh Malhotra appointed as executive directors.
- Three new independent directors appointed to the Board for 5 years.
Price Impact
More from KRONOX